Abstract:This study analysed the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, group 4 had lower clinical pregnancy and live birth rates as well as the highest ectopic pregnancy rate (29.15% versus 45.91%; 18.67% versus 34.34%; 18.10% versus 5.82%; P<0.05). Group 3 had lower clinical pregnancy and live birth rates per embryo-transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively; P<0.05). Clinical pregnancy rates were similar in frozen-thawed embryo transfers (FET) among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. High serum oestradiol concentration on HCG day did not affect the IVF pregnancy outcome. In combination with the elevated progesterone, high oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes. The aim of this study was to analyse the relationship between serum progesterone/oestradiol concentrations and IVF pregnancy outcomes in gonadotrophin-releasing hormone agonist protocols. A total of 2921 infertile women undergoing IVF were assigned to four groups according to their serum progesterone and oestradiol concentrations on the day of human chorionic gonadotrophin (HCG) administration: group 1 (control) progesterone<3.34 nmol/l and oestradiol<19,124 pmol/l; group 2 (high oestradiol); group 3 (high progesterone); group 4 (high progesterone and high oestradiol). Compared with group 1, patients in group 4 had lower clinical pregnancy (29.15% versus 45.91%) and live birth rates (18.67% versus 34.34%) as well as the highest ectopic pregnancy rate (18.1% versus 5.82%) (all P<0.05). Those in group 3 had lower clinical pregnancy and live birth rates per embryo transfer cycle (29.78% versus 45.91%; 20.28% versus 34.34%, respectively, P<0.05). Embryo quality appeared to be unaffected since similar clinical pregnancy rates in frozen-thawed embryo transfer (FET) cycles among the four groups. In conclusion, elevated progesterone was detrimental to live birth rates. A high serum oestradiol concentration on the day of HCG administration did not affect the IVF pregnancy outcome. In combination with the elevated progesterone and oestradiol concentrations had a potential negative effect. For these patients, FET should be suggested to improve the pregnancy outcomes.

Roles of estradiol levels on the day of human chorionic gonadotrophin administration in the live birth of patients with frozen embryo transfer

Association Between Serum Estradiol Level on the Human Chorionic Gonadotrophin Administration Day and Clinical Outcome.

The effect of different estradiol concentrations on the day of HCG administration on pregnancy outcome of fresh IVF cycles and subsequent frozen-thawed embryo transfer cycles

Estradiol on Trigger Day was Irrelevant to Live Birth Rates of Fresh Cycles but Positively Associated with Cumulative Live Birth Rates: A Multicenter Retrospective Study

Serum estradiol level change after human chorionic gonadotropin administration had no correlation with live birth rate in IVF cycles.

Mid-luteal serum estradiol levels are associated with Live birth rates in Hormone Replacement Therapy Frozen Embryo Transfer (FET) cycles – a cohort study

Effect of serum estradiol and progesterone level and progesterone/estradiol ratio on the day of human chorionic gonadotropin administration in pregnancy outcome of in vitro fertilization-embryo transplantation

Estradiol change after HCG administration and clinical outcome in IVF long protocol ovulation induction cycle

Influence of serum estradiol mass concentrations on day of hCG administration during in vitro fertilization on pregnancy outcomes

THE RELATIONSHIP BETWEEN SERUM ESTROGEN (E2) LEVELS AND OUTCOMES OF HORMONE REPLACEMENT THERAPY-FROZEN EMBRYO TRANSFER (HRT-FET).

Estradiol on Trigger Day: Irrelevant to Live Birth Rates of Fresh Cycles but Positively Associated with Cumulative Live Birth Rates.

The influence of progesterone and estradiol level on the day on clinical outcome of frozen thawed embryo transfer in nature cycle.

The Relationship Between Serum Oestrogen Levels and Clinical Outcomes of Hormone Replacement Therapy-Frozen Embryo Transfer: a Retrospective Clinical Study.

Serum Estradiol Level and Progesterone/Estradiol Ratio Per Follicle on HCG Administration Day in Relation to Outcomes of in Vitro Fertilization and Embryo Transfer

Analysis of Decreased Serum Estradiol Level after Human Chorionic Gonadotropin Administration During Controlled Ovarian Hyperstimulation

Association between serum oestradiol level on the hCG administration day and neonatal birthweight after IVF-ET among 3659 singleton live births

Estradiol-to-follicle ratio on human chorionic gonadotropin day is a novel predictor of gestational diabetes mellitus in women receiving fresh embryo transfer

The value of progesterone-to-estradiol ratio on the day of hCG administration in predicting pregnancy result of IVF-ET in normo-responders undergoing GnRH antagonist cycles

The Relation of Serum Ration of E_2 and Progesterone-Estradiol Ration on Pregnancy Rate in IVF Cycle

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

Peri-implantation estradiol level has no effect on pregnancy outcome in vitro fertilization- embryo transfer